HOUSTON, TX, US
Diakonos Oncology Corp
From the company
Diakonos Oncology is a clinical-stage biotechnology company developing a Dendritic Cell Vaccine (DCV) called DOC1021 (also known as dubodencel) for difficult-to-treat cancers. Its proprietary patented 'double-loading' technique tricks the body into perceiving cancer cells as virally infected cells. The company received FDA Fast Track designation and is based on research conducted at Baylor College of Medicine, working with institutions such as MD Anderson and UTHealth Houston.
Capabilities
Products & services
Direct lines
Contact
Share quantities, requirements, and timing.
Send requirementsCompany record
Profile information
- Founded
- 2022
- Website
- www.diakonosoncology.com
Source: company website
Start a conversation
Send your requirements
Quantities, certifications, delivery timing, and anything else needed to quote the work.